AILEEN ROBITAILLE: Open Payments
NPI 1760744148 · HINSDALE, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,021 in 41 payments from 7 companies in 2025. Trend: 2023 $3,119 · 2024 $635 · 2025 $1,021
Food & beverage: $872Education: $149
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 11 | $409 |
| Janssen Biotech, Inc. | 19 | $367 |
| Regeneron Healthcare Solutions, Inc. | 5 | $125 |
| Novartis Pharmaceuticals Corporation | 2 | $46 |
| PFIZER INC. | 2 | $29 |
| UCB, Inc. | 1 | $28 |
| Galderma Laboratories, L.P. | 1 | $16 |
Products named: DUPIXENT, TREMFYA, COSENTYX, LIBTAYO, CIBINQO, Bimzelx, NEMLUVIO.
Industry payments across IL — which companies pay providers there.
